McKinley Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-425
| Closed | -$21K | – | 291 |
|
|
2019
Q1 | $21K | Hold |
425
| – | – | ﹤0.01% | 270 |
|
|
2018
Q4 | $17K | Sell |
425
-427
| -50% | -$17.1K | ﹤0.01% | 282 |
|
|
2018
Q3 | $59K | Sell |
852
-73
| -8% | -$5.06K | ﹤0.01% | 278 |
|
|
2018
Q2 | $70K | Sell |
925
-73
| -7% | -$5.52K | ﹤0.01% | 286 |
|
|
2018
Q1 | $52K | Sell |
998
-29,291
| -97% | -$1.53M | ﹤0.01% | 301 |
|
|
2017
Q4 | $1.62M | Buy |
30,289
+56
| +0.2% | +$2.99K | 0.08% | 177 |
|
|
2017
Q3 | $1.8M | Buy |
30,233
+12,768
| +73% | +$761K | 0.07% | 171 |
|
|
2017
Q2 | $1.38M | Buy |
+17,465
| New | +$1.38M | 0.05% | 199 |
|